Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review

Toxoplasmosis treatment with diphenyl diselenide in infected mice modulates the activity of purinergic enzymes and reduces inflammation in spleen

(2017) Pedro H. Doleski et al.   EXPERIMENTAL PARASITOLOGY

Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii

(2017) Florentine U. Rutaganira et al.   JOURNAL OF MEDICINAL CHEMISTRY

Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract

(2017) Beatriz Eugenia Fuentes-Castro et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites

(2017) Yuho Murata et al.   PLoS One

Diphenyl diselenide modulates nucleotidases, reducing inflammatory responses in the liver of Toxoplasma gondii-infected mice

(2017) Pedro H. Doleski et al.   Purinergic Signalling

Toxoplasma gondii: Effects of diphenyl diselenide in experimental toxoplasmosis on biomarkers of cardiac function

(2016) Vanessa S. Machado et al.   EXPERIMENTAL PARASITOLOGY

Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis

(2016) Rama Subba Rao Vidadala et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii

(2016) Nathieli B. Bottari et al.   MICROBIAL PATHOGENESIS

Biotherapic of Toxoplasma gondii reduces parasite load, improves experimental infection, protects myenteric neurons and modulates the immune response in mice with toxoplasmosis

(2016) Caroline Felicio Braga-Silva et al.   European Journal of Integrative Medicine

Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii

(2015) Lobna A. El-Zawawy et al.   ACTA TROPICA

Effect of 3-Bromopyruvate and Atovaquone on Infection duringIn VitroInteraction of Toxoplasma gondii and LLC-MK2 Cells

(2015) Loyze Paola O. de Lima et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Guanabenz Repurposed as an Antiparasitic with Activity against Acute and Latent Toxoplasmosis

(2015) Imaan Benmerzouga et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Could miltefosine be used as a therapy for toxoplasmosis?

(2015) Maha M. Eissa et al.   EXPERIMENTAL PARASITOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Inhibitors of eIF2α Dephosphorylation Slow Replication and Stabilize Latency in Toxoplasma gondii

(2013) Christian Konrad et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bradyzoite Pseudokinase 1 Is Crucial for Efficient Oral Infectivity of the Toxoplasma gondii Tissue Cyst

(2013) Kerry R. Buchholz et al.   EUKARYOTIC CELL

Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii

(2013) Sebastian Lourido et al.   JOURNAL OF MEDICINAL CHEMISTRY

Significant Reduction of Brain Cysts Caused by Toxoplasma gondii after Treatment with Spiramycin Coadministered with Metronidazole in a Mouse Model of Chronic Toxoplasmosis

(2012) Wai Kit Chew et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New naphthoquinones and an alkaloid with in vitro activity against Toxoplasma gondii RH and EGS strains

(2012) Ronize Andréia Ferreira et al.   EXPERIMENTAL PARASITOLOGY

Disease burden of foodborne pathogens in the Netherlands, 2009

(2012) Arie H. Havelaar et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis

(2012) J. S. Doggett et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

In-vivo efficacy of toltrazuril on experimentally induced Toxoplasma gondii tissue cysts in lambs: A novel strategy for prevention of human exposure to meat-borne toxoplasmosis

(2012) Oguz Kul et al.   RESEARCH IN VETERINARY SCIENCE

Activity of the Histone Deacetylase Inhibitor FR235222 on Toxoplasma gondii: Inhibition of Stage Conversion of the Parasite Cyst Form and Study of New Derivative Compounds

(2010) D. Maubon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Toxoplasma gondii: Fluconazole and itraconazole activity against toxoplasmosis in a murine model

(2010) Érica S. Martins-Duarte et al.   EXPERIMENTAL PARASITOLOGY

Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation

(2010) Orli Megged et al.   PEDIATRIC TRANSPLANTATION

Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites

(2009) Alexandre Bougdour et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Toxoplasma gondii infection in humans and animals in the United States

(2008) J DUBEY et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Evaluation of the Mood-Stabilizing Agent Valproic Acid as a Preventative for Toxoplasmosis In Mice and Activity Against Tissue Cysts in Mice

(2008) David G. Goodwin et al.   JOURNAL OF PARASITOLOGY